 Odonate Therapeutics, Inc. NASDAQ: ODT, Dyadic International, Inc. NASDAQ: DYAI and Marker Therapeutics, Inc. NASDAQ: MRKR are among the early biotech movers in Mondays session. Odonate to Shut Shop: Odonate, an oncology-focused pharma company, said it is discontinuing the development of tesetaxel following feedback from the Food and Drug Administration in a pre-New Drug Application meeting. 